In the case of primary brain tumor, isolation of circulating brain tumor cells from patient with glioblastoma (GBM) has been challenging in the past years, mostly because brain tumor cells lack the expression of biomarkers used for most of CTC detection strategies (EpCAM, CD326).63, 64. This evidence concerns the gene EPCAM and glioblastoma.